Exagen, Inc. (XGN) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1153913,
    "name": "Exagen, Inc.",
    "stock_name": "Exagen, Inc.",
    "full_name": "Exagen, Inc.",
    "name_url": "stocks-analysis/exagen-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "7.49",
    "chg": 0.39,
    "chgp": "5.49%",
    "dir": 1,
    "prev_price": "7.10",
    "mcapval": "215.86",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 3365,
    "indexname": "S&P 500",
    "isin": "US30068X1037",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "313.23 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/exagen-inc-1153913-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Exagen, Inc. Hits New 52-Week High of $11.99, Surging 498.99%",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/exagen-inc-hits-new-52-week-high-of-1199-surging-49899-3626646",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/ExagenInc_priceRelatedfactors_3626646.png",
        "date": "2025-10-16 18:22:21",
        "description": "Exagen, Inc. has achieved a new 52-week high of USD 11.99, reflecting a remarkable year-over-year performance increase of 498.99%. With a market capitalization of USD 216 million, the company operates in a competitive pharmaceuticals and biotechnology sector, showcasing resilience despite its current loss-making status."
      },
      {
        "title": "Exagen, Inc. Hits New 52-Week High of $11.75, Up 479.9% Year-Over-Year",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/exagen-inc-hits-new-52-week-high-of-1175-up-4799-year-over-year-3622804",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/ExagenInc_priceRelatedfactors_3622804.png",
        "date": "2025-10-15 17:02:38",
        "description": "Exagen, Inc., a microcap in the Pharmaceuticals & Biotechnology sector, achieved a new 52-week high of USD 11.75 on October 14, 2025, reflecting a substantial annual increase. Despite this performance, the company remains unprofitable, with a negative price-to-earnings ratio and a high price-to-book ratio, highlighting sector volatility."
      },
      {
        "title": "Exagen, Inc. Hits New 52-Week High of $11.09, Surging 447%",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/exagen-inc-hits-new-52-week-high-of-1109-surging-447-3579366",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/ExagenInc_priceRelatedfactors_3579366.png",
        "date": "2025-09-29 14:24:35",
        "description": "Exagen, Inc. has achieved a new 52-week high of USD 11.09, reflecting a significant performance improvement over the past year with a gain of 447.24%. Despite its loss-making status, the company has a market capitalization of USD 216 million and faces challenges with negative return on equity and a high price-to-book ratio."
      },
      {
        "title": "Exagen, Inc. Hits New 52-Week High of $10.83, Up 441.71%",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/exagen-inc-hits-new-52-week-high-of-1083-up-44171-3571331",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/9/ExagenInc_priceRelatedfactors_3571331.png",
        "date": "2025-09-25 16:46:47",
        "description": "Exagen, Inc. has achieved a new 52-week high, reflecting a significant increase in its stock performance over the past year. With a market capitalization of USD 216 million, the company faces challenges, including a negative return on equity and a high price-to-book ratio, as it competes in the biotechnology sector."
      },
      {
        "title": "Is Exagen, Inc. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-exagen-inc-technically-bullish-or-bearish-3546597",
        "imagepath": "",
        "date": "2025-09-20 19:36:34",
        "description": "As of 11 September 2025, the technical trend for Exagen, Inc. has changed from mildly bullish to bullish. The weekly and monthly MACD indicators are both bullish, while the daily moving averages also indicate a bullish stance. However, the monthly RSI is bearish, and the KST shows a mildly bearish signal on the weekly timeframe. The Bollinger Bands are mildly bullish on both weekly and monthly charts. Overall, the technical stance is bullish but with some mixed signals, particularly from the RSI and KST.\n\nIn terms of performance, Exagen has significantly outperformed the S&P 500 year-to-date with a return of 135.37% compared to the S&P 500's 12.22%, and over the past year, it has returned 239.79% against the S&P 500's 17.14%...."
      }
    ],
    "total": 9,
    "sid": "1153913",
    "stock_news_url": "https://www.marketsmojo.com/news/exagen-inc-1153913"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Exagen, Inc. Hits New 52-Week High of $11.99, Surging 498.99%

2025-10-16 18:22:21

Exagen, Inc. has achieved a new 52-week high of USD 11.99, reflecting a remarkable year-over-year performance increase of 498.99%. With a market capitalization of USD 216 million, the company operates in a competitive pharmaceuticals and biotechnology sector, showcasing resilience despite its current loss-making status.

Exagen, Inc. Hits New 52-Week High of $11.75, Up 479.9% Year-Over-Year

2025-10-15 17:02:38

Exagen, Inc., a microcap in the Pharmaceuticals & Biotechnology sector, achieved a new 52-week high of USD 11.75 on October 14, 2025, reflecting a substantial annual increase. Despite this performance, the company remains unprofitable, with a negative price-to-earnings ratio and a high price-to-book ratio, highlighting sector volatility.

Exagen, Inc. Hits New 52-Week High of $11.09, Surging 447%

2025-09-29 14:24:35

Exagen, Inc. has achieved a new 52-week high of USD 11.09, reflecting a significant performance improvement over the past year with a gain of 447.24%. Despite its loss-making status, the company has a market capitalization of USD 216 million and faces challenges with negative return on equity and a high price-to-book ratio.

Exagen, Inc. Hits New 52-Week High of $10.83, Up 441.71%

2025-09-25 16:46:47

Exagen, Inc. has achieved a new 52-week high, reflecting a significant increase in its stock performance over the past year. With a market capitalization of USD 216 million, the company faces challenges, including a negative return on equity and a high price-to-book ratio, as it competes in the biotechnology sector.

Is Exagen, Inc. technically bullish or bearish?

2025-09-20 19:36:34

As of 11 September 2025, the technical trend for Exagen, Inc. has changed from mildly bullish to bullish. The weekly and monthly MACD indicators are both bullish, while the daily moving averages also indicate a bullish stance. However, the monthly RSI is bearish, and the KST shows a mildly bearish signal on the weekly timeframe. The Bollinger Bands are mildly bullish on both weekly and monthly charts. Overall, the technical stance is bullish but with some mixed signals, particularly from the RSI and KST. In terms of performance, Exagen has significantly outperformed the S&P 500 year-to-date with a return of 135.37% compared to the S&P 500's 12.22%, and over the past year, it has returned 239.79% against the S&P 500's 17.14%....

View All News